Foundayo (orforglipron) became available through LillyDirect on April 6, 2026. That's three days ago. So let's be honest upfront: we do not have meaningful real-world data yet. What we do have is a combination of clinical trial data that tells us what to expect in the first weeks, and early patient reports that are starting to trickle in from forums, social media, and patient communities. Here's the reality check.
What Clinical Trials Tell Us About Week 1
In the Phase 3 trials that led to Foundayo's approval, here's what happened during the first month on the 0.8 mg starting dose:
- Weight loss: Minimal. Expect 1–2 lbs in the first week, if any. The starting dose is a titration dose designed to let your body adjust — not a therapeutic dose for weight loss
- Appetite changes: Subtle. Some patients notice slightly reduced appetite within the first few days, but dramatic appetite suppression doesn't typically occur until higher doses
- GI side effects: The most common early experience. In trials, approximately 30% of patients reported some nausea during the titration period, with most describing it as mild
For a detailed week-by-week breakdown of what to expect, see our Foundayo weight loss timeline.
What Early Patients Are Saying
Based on initial reports from patient forums, Reddit communities, and social media in the first 72 hours:
Positive Feedback
- Convenience is the standout. The most consistent praise is about how easy Foundayo is to take — a daily pill with no fasting requirements, no injection anxiety, no refrigeration needed. Multiple patients have noted how different this feels from Ozempic or Wegovy
- LillyDirect ordering was smooth. Most early adopters report that the online consultation and ordering process through LillyDirect took 15-30 minutes, with medication arriving within 2-3 business days
- Starting price reception is positive. At $149/month for the starting dose, patients are expressing relief compared to the sticker shock of injectable GLP-1s
- Subtle appetite effects noted. Some patients report noticing a mild reduction in snacking urges or food noise within the first 2-3 days — though this is highly individual and may partly be placebo at this early stage
Mixed or Negative Feedback
- GI effects are real but manageable. Several patients report mild nausea, particularly in the first 1-2 hours after taking the pill. Most describe it as noticeably less intense than what they experienced starting injectable semaglutide
- No dramatic changes yet. Some patients expected faster results. This is a expectations management problem, not a drug problem — the starting dose is designed for tolerability, not maximum efficacy
- Questions about dose escalation. Patients want to know how quickly they'll move to higher doses and when they'll start seeing real weight loss. For details on the titration schedule, see our Foundayo side effects week by week guide
What NOT to Expect in Week 1
Setting realistic expectations is the single most important thing you can do when starting Foundayo. Here's what will not happen in your first week:
- Dramatic weight loss. You are on the lowest titration dose. Meaningful weight loss begins during month 2-3 as doses increase. Clinical trials showed the majority of weight loss occurring between months 3 and 9
- Complete appetite suppression. The "I forgot to eat" effect that GLP-1 patients describe typically develops at higher doses. At 0.8 mg, the appetite effect is subtle
- Zero side effects. Most patients will experience at least mild GI symptoms. Having no nausea at all is actually less common than having mild nausea. See our Foundayo nausea tips for management strategies
- Immediate validation. If you step on a scale every morning expecting dramatic changes, you will be disappointed. Give it time
Realistic Expectations by Month
| Timeframe | Dose (typical) | What to Expect |
|---|---|---|
| Week 1-2 | 0.8 mg | Body adjusting, mild GI effects, 0-2 lbs |
| Month 1 | 0.8 mg | GI effects improving, appetite slightly reduced, 2-4 lbs |
| Month 2 | 1.2-2.4 mg | Dose escalation begins, appetite suppression noticeable, 4-8 lbs |
| Month 3-6 | 2.4-4.8 mg | Peak weight loss rate, 1-2 lbs/week, significant appetite reduction |
| Month 6-12 | 4.8 mg (maintenance) | Weight loss continues but slows, approaching plateau |
By 12 months at the full dose, clinical trials showed an average of 12.4% total body weight loss. For a 220 lb person, that's approximately 27 lbs. Results vary significantly between individuals.
Tips from Early Adopters
Based on what's working for patients in the first few days:
- Take it at the same time every day. Consistency helps your body adjust and helps you remember
- Don't take it on a completely empty stomach if nausea is an issue — a small snack beforehand can help
- Stay hydrated. This is generic advice, but GLP-1 patients consistently report that dehydration worsens GI side effects
- Track your experience. Keep a simple log of symptoms, meals, and weight. This data is invaluable when you discuss dose adjustments with your prescriber
- Don't compare day-to-day. Weight fluctuates 2-5 lbs daily from water, food, and other factors. Compare weekly averages, not daily snapshots
We'll Keep Updating This
This article is a snapshot of the earliest possible real-world data — literally the first 72 hours of Foundayo availability. We will update it regularly as more patients share their experiences and as the first weeks turn into months. Bookmark this page and check back for updates.
In the meantime, for the most comprehensive clinical data on what to expect, see our Foundayo weight loss timeline and side effects week-by-week guide.
Bottom Line
It's too early for real-world conclusions about Foundayo. What we can say: early patients are impressed by the convenience and pricing, mildly annoyed by GI side effects, and learning that a daily pill doesn't produce overnight results. Clinical trial data tells us the payoff comes in months 3-9 as doses escalate. If you've just started Foundayo, give it time, manage expectations, and report any concerns to your prescriber.